Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer
Completed · Phase 1/Phase 2
Conditions studied: Colorectal Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Oblimersen may increase the effectiveness of chemotherapy by making tumor cells more sensitive to the drugs. PURPOSE: Phase I/II trial to study the effectiveness of combining oxaliplatin, fluorouracil, and leucovorin with oblimersen in treating patients who have unresectable, metastatic, or recurrent colorectal cancer.
Key facts
- Study ID
- NCT00055822
- Run by
- The University of Texas Health Science Center at San Antonio
- People needed
- 16
- Starts
- 2002-10-01
- Expected to finish
- 2004-10-01
- Last updated by the study team
- 2012-07-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- San Antonio Cancer Institute — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.